Yahoo Finance·2025-11-12 14:37Core Insights - Investing in struggling stocks can be risky but may yield substantial returns if the company successfully turns around its performance [1] Group 1: Intel - Intel's shares fell 60% last year due to rising losses and concerns about its fabrication business, with a net loss of $18.8 billion and a 2% revenue decline to $53.1 billion in 2024 [4] - In 2025, Intel's shares rebounded by approximately 85%, significantly outperforming the S&P 500's 14% gain, driven by a deal with the U.S. government for a 10% stake and a $5 billion investment from Nvidia [5] - Intel reported a modest operating profit of $683 million for the period ending September 27, with a 3% revenue increase to $13.7 billion, but its stock is now trading at a forward P/E multiple of 56, indicating it may be too expensive to buy at current levels [6] Group 2: CVS Health - CVS Health's stock dropped 43% in 2024 due to disappointing quarterly results, leading to a CEO change from Karen Lynch to David Joyner [9] - Under new leadership, CVS Health's revenue increased by 8% to $296.4 billion in the first nine months of 2025, despite incurring a loss of $1.2 billion, which included $5.7 billion in goodwill impairment charges [10]